BMJ22h
POS0471 CONTINUOUSLY LOW MUSCLE MASS CONTRIBUTES TO WORSE PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS: A 5-YEAR FOLLOW-UP STUDY
Those who finished at-least 5 years followed up were eligible in this study. Clinical data, including RA disease activity (DAS28-ESR, DAS28-ESR, SDAI and CDAI) and physical function indicator (HAQ-DI) ...
dermatologyadvisor11h
Patients With Rheumatoid Arthritis Face Higher COVID-19 Risks
Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...
clinicalpainadvisor.com12h
Higher Adalimumab Trough Levels Improve Outcomes in Rheumatoid Arthritis
Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...
Endocrinology Advisor23h
Early Treatment Escalation Fails to Mitigate Risk of Developing D2T RA
Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...
JD Supra8h
Adapting to the IRA: Early Lessons Learned on the IRA’s Impact on Deal-Making, Drug Economics, and Business Strategy
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...